Stocks · Health care · Pharmaceutical Preparations

Latigo Biotherapeutics, Inc.

LTGO
United States Fiscal year ends December CIK 0002056611
16.00
+8.18%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
16.00 on 9 Oct 2026
25 20 15 Aug 2026 Sep 2026 Oct 2026 7 Aug 2026 $18.25 10 Aug 2026 $18.56 11 Aug 2026 $18.52 12 Aug 2026 $19.38 13 Aug 2026 $20.06 14 Aug 2026 $19.49 17 Aug 2026 $19.30 18 Aug 2026 $20.00 19 Aug 2026 $20.94 20 Aug 2026 $21.40 21 Aug 2026 $22.37 24 Aug 2026 $22.00 25 Aug 2026 $22.57 26 Aug 2026 $24.13 27 Aug 2026 $25.00 28 Aug 2026 $24.23 31 Aug 2026 $22.02 1 Sep 2026 $22.26 2 Sep 2026 $21.77 3 Sep 2026 $22.48 4 Sep 2026 $23.04 8 Sep 2026 $23.73 9 Sep 2026 $22.80 10 Sep 2026 $21.54 11 Sep 2026 $22.15 14 Sep 2026 $22.64 15 Sep 2026 $23.01 16 Sep 2026 $23.06 17 Sep 2026 $23.93 18 Sep 2026 $22.55 21 Sep 2026 $21.11 22 Sep 2026 $20.82 23 Sep 2026 $19.97 24 Sep 2026 $17.76 25 Sep 2026 $17.15 28 Sep 2026 $17.48 29 Sep 2026 $18.10 30 Sep 2026 $16.70 1 Oct 2026 $16.69 2 Oct 2026 $15.90 5 Oct 2026 $16.63 6 Oct 2026 $16.26 7 Oct 2026 $15.52 8 Oct 2026 $14.79 9 Oct 2026 $16.00 Tananbaum James B. Director Bought $2.52M 10 Aug 2026 · at $18.00 · 7.5% of stake Foresite Capital Management V… 10% owner Bought $2.52M 10 Aug 2026 · at $18.00 · 7.5% of stake
2 buys0 sales at will0 planned sales

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
10 Aug 2026 Foresite Capital Management V, LLC
10% owner
Bought $2.52M 7.5%
10 Aug 2026 Tananbaum James B.
Director
Bought $2.52M 7.5%